Skip to main content
Premium Trial:

Request an Annual Quote

UCB Renews Agreement for Genedata's Phylosopher and Expressionist Platforms

NEW YORK (GenomeWeb News) —Genedata said today that UCB has renewed and expanded an agreement to use two Genedata software platforms in its lead discovery research.
 
The new agreement will allow UCB to use Genedata's Phylosopher and Expressionist software in its biologics and lead-finding studies for central nervous system disorders and autoimmune and inflammatory disorders that are conducted in the UK and Belgium.
 
The Expressionist biomarker research software includes public and private data and sample information, and its functions have been expanded to include data from UCB’s molecular profiling technology portfolio. The Phylosopher database integrates links between genome sequences and transcriptomics, proteomic and metabolic data, and other information and annotations, as well as disease-relevant phenotype information.
 
Financial terms of the agreement were not released.

Filed under

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.